Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 57

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 57
---
 —        |   |     | $                                                                                 |  10,582 |     | $                                                                                                                         | —       |     | $                                                                                                                                          | — |     | $                                                                                                                                                                    | — |     | $               | 9,897,903 |     | -8 |

(3) The dollar amounts reported in column (e) represent the average of the amounts reported for the NEOs as a group (excluding the current PEO and the former PEO in each respective year) in the “Total” column of the Summary Compensation Table in each applicable year. The NEOs (excluding the current PEO and the former PEO) included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2024, Ira Duarte, and William Forbes, (ii) for 2023, Ira Duarte, William Forbes, and David Szekeres; (iii) for 2022, Kimberly Manhard, and David Szekeres and (iv) for 2021, Kimberly Manhard, John Poyhonen, David Szekeres and Lisa Peraza.

(4) The dollar amounts reported in column (f) represent the average amount of “compensation actually paid” to the NEOs as a group (excluding the current PEO and the former PEO), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding the current PEO and the former PEO) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the NEOs as a group (excluding the current PEO and the former PEO) for fiscal years 2023 and 2024 to determine the compensation actually paid, using the same methodology described above (2023 is included due to the administrative error correction described in footnote 8):

| Year |     | Average Reported   
 Summary            
 Compensation Table 
 Total for Non-PEO  
 NEOs ($)           |           |     | Average Reported  
 Value of Equity   
 Awards - NEOs ($) |          |   |    |     | Average Equity    
 Award Adjustments 
 - NEOs ($)        |           |     |    | Average Compensation  
 Actually Paid to Non- 
 PEO NEOs ($)          |           |     |    |
|:-----|:----|:----------------